November 5, 2025 — Leads & Copy —
Cambridge, MA — KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) will participate in fireside chats at the Stifel 2025 Healthcare Conference on Nov. 12 at 8:40 a.m. EST and the Jefferies Global Healthcare Conference in London on Nov. 19 at 1:30 p.m. GMT.
Live audio webcasts will be accessible on the Investors section of KalVista’s website, with archived replays available about two hours after the events conclude.
KalVista is focused on creating oral therapies for rare diseases. Its team discovered and developed EKTERLY®, an oral on-demand treatment for hereditary angioedema (HAE). KalVista works to improve treatment and care for HAE.
For more about KalVista, visit the company’s website and follow them on LinkedIn, X, Facebook and Instagram.
Source: KalVista Pharmaceuticals, Inc.
